Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer

BACKGROUND: Bladder cancer (BLCA) is a malignant tumor with a dismay outcome. Increasing evidence has confirmed that chromatin regulators (CRs) are involved in cancer progression. Therefore, we aimed to explore the function and prognostic value of CRs in BLCA patients. METHODS: Chromatin regulators...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ke, Liu, Xiaoqiang, Deng, Wen, Wang, Gongxian, Fu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819906/
https://www.ncbi.nlm.nih.gov/pubmed/35125116
http://dx.doi.org/10.1186/s41065-021-00212-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819906/
https://www.ncbi.nlm.nih.gov/pubmed/35125116
http://dx.doi.org/10.1186/s41065-021-00212-x

Ejemplares similares